Preclinical evaluation of immunomodulatory effects of aurora kinase inhibition in HPV plus cancers

被引：1
|
作者：
Sinha, Pragya
Ghosh, Soma
Johnson, Faye M.
Sastry, Jagannadha K.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5021
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Irradiation plus Hsp90 inhibition: Induction of immunomodulatory anti-tumor effects
    Ernst, A.
    Kapfhammer, H.
    Zuchtriegel, G.
    Uhl, B.
    Reichel, C.
    Winssinger, N.
    Belka, C.
    Lauber, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 : S71 - S72
  • [22] Aurora kinase A inhibition plus Tumor Treating Fields suppress glioma cell proliferation in a cilium-independent manner
    Tian, Jia
    Mallinger, Julianne C.
    Shi, Ping
    Ling, Dahao
    Deleyrolle, Loic P.
    Lin, Min
    Khoshbouei, Habibeh
    Sarkisian, Matthew R.
    TRANSLATIONAL ONCOLOGY, 2024, 45
  • [23] Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer
    Wunderlich, Annette
    Fischer, Melina
    Schlosshauer, Torsten
    Ramaswamy, Annette
    Greene, Brandon H.
    Brendel, Cornelia
    Doll, Dietrich
    Bartsch, Detlef
    Hoffmann, Sebastian
    CANCER SCIENCE, 2011, 102 (04) : 762 - 768
  • [24] Structure-Based Rational Design and Evaluation of BET-Aurora Kinase Dual-Inhibitors for Treatment of Cancers
    Lyu, Kaikai
    Ren, Ying
    Mou, Jie
    Yang, Yunfang
    Pan, Yaoyao
    Zhang, Huijie
    Li, Yanlian
    Cao, Danyan
    Chen, Lin
    Chen, Danqi
    Guo, Dong
    Xiong, Bing
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 68 (02) : 1344 - 1364
  • [25] AZD1152, highly potent Aurora kinase inhibitor, with selectivity for Aurora kinase B, induces pharmacodynamic effects and significant growth inhibition in human tumor xenograft models.
    Wilkinson, RW
    Odedra, R
    Heaton, SP
    Keen, N
    Wedge, SR
    Brown, E
    Crafter, C
    Foote, KM
    Mortlock, AA
    Jung, FH
    Heron, NM
    Brady, MC
    Khatri, L
    Foster, JJ
    Green, S
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9085S - 9085S
  • [26] The combination of TRIP13 and Aurora kinase A inhibition caused cell cycle specific DNA damage and death in Rb-deficient cancers
    Yapindi, Lacin
    Ghosh, Soma
    Mazumdar, Tuhina
    Johnson, Faye M.
    CANCER RESEARCH, 2024, 84 (01)
  • [27] Design, synthesis, and biological evaluation of polyphenols with 4,6-diphenylpyrimidin-2-amine derivatives for inhibition of Aurora kinase A
    Young Han Lee
    Jihyun Park
    Seunghyun Ahn
    Youngshim Lee
    Junho Lee
    Soon Young Shin
    Dongsoo Koh
    Yoongho Lim
    DARU Journal of Pharmaceutical Sciences, 2019, 27 : 265 - 281
  • [28] Design, synthesis, and biological evaluation of polyphenols with 4,6-diphenylpyrimidin-2-amine derivatives for inhibition of Aurora kinase A
    Lee, Young Han
    Park, Jihyun
    Ahn, Seunghyun
    Lee, Youngshim
    Lee, Junho
    Shin, Soon Young
    Koh, Dongsoo
    Lim, Yoongho
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 27 (01) : 265 - 281
  • [29] Rb deficient HPV plus HNSCC experienced enhanced sensitivity to aurora kinase inhibitors by altering the balance of MAD2 and TRIP13 levels
    Ghosh, Soma
    Mazumdar, Tuhina
    Xu, Wei
    Powell, Reid T.
    Stephan, Clifford
    Shen, Li
    Pickering, Curtis R.
    Wang, Jing
    Johnson, Faye M.
    CANCER RESEARCH, 2022, 82 (12)
  • [30] Novel combination of TRIP13 and Aurora kinase A inhibition demonstrated extensive DNA damage and immunogenic cell death in RB-deficient cancers
    Ghosh, Soma
    Mazumdar, Tuhina
    Sinha, Pragya
    Yapindi, Lacin
    Sastry, Jagannadha
    Johnson, Faye M.
    CLINICAL CANCER RESEARCH, 2023, 29 (18)
12345